Page 1 | Page 2 | Page 3 | Page 5

 

                                                                       Page 4; Vol. 1 No. 2

 

 

 

What's New:


Updated Biofilm Website – Our biofilm website has received considerable accolades and we are quite proud of its utilization.  It was constructed so as to be useful and allows me on an international scale to continually refer to our clinical tools for education on a world wide scale. 
We have added two new sections:   The first, entitled “Translational Research” highlights, with figures, key points of our philosophy and the driving influence of our 4 Translational Research Models:

  1. Biofilm Model
  2. Antibiotic Resistance Model
  3. Outcomes Model
  4. Global Oral Hygiene

Please review it as it highlights our working hypotheses and continual growth in elaboration of biofilm structure, communication and pathogenecity. 

“Mini-Microbiology,” the second is in response to invited lectures and presentations on the national/international scene.  Many have asked me to upload my complete presentation and this, at times, is contradictory to the request of our supporting vendors given the data is often as new as we can present  Hence, we have compromised and have provided in four 30-minute presentations, “Mini-microbiology” slides that represent the newest information:

  1. “Biofilms: Architects of Survival,” covers biofilm structure and pathogenecity with the resulting diseases.
  2. “Medical/Dental Biofilms: Architects of Chronic Diseases Head to Toe,” discusses the impact of biofilms on dental and medical diseases emphasizing dental and the potential link in systemic diseases.
  3. “A Comprehensive Engineered Ventilator-Endotrach-Lung (VEL) Model: Unmasking VAP,” highlights our use of modeling, particularly the ventilator endotrach lung (VEL) model which has been so robustly supported by TycoHealthcare and the use of silver impregnated endotrachs in reducing biofilm luminal colonization.  This also highlights some of our awareness of the micro to macro concept realizing that biofilms reduce the lumen of the endotrach, increase the work of breathing, and act as a reservoir of late stage pathogens, i.e. candida and pseudomonas.
  4. “Diagnostic Microbiology, Pathology and Biofilms” is our attempt to upgrade microbiology in its relation to biofilms and the use of new assays applicable to diagnostic and clinical microbiology.  Biofilms is still a foreign concept and provides limited tests methodology.